Cargando…
Mesenchymal stem cells-based therapy in liver diseases
Multiple immune cells and their products in the liver together form a complex and unique immune microenvironment, and preclinical models have demonstrated the importance of imbalances in the hepatic immune microenvironment in liver inflammatory diseases and immunocompromised liver diseases. Various...
Autores principales: | Han, Heng-Tong, Jin, Wei-Lin, Li, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326420/ https://www.ncbi.nlm.nih.gov/pubmed/35895169 http://dx.doi.org/10.1186/s43556-022-00088-x |
Ejemplares similares
-
Mesenchymal stem cell therapy for liver disease: full of chances and challenges
por: Yang, Xue, et al.
Publicado: (2020) -
A pooled analysis of mesenchymal stem cell-based therapy for liver disease
por: Zhao, Lu, et al.
Publicado: (2018) -
Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease
por: Han, Jinsol, et al.
Publicado: (2022) -
Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019) -
Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015)